NEW YORK (GenomeWeb News) – Nanosys today said that it has licensed patents and patent applications covering the use of nanowires for biosensors to QuantuMDx Group.

The non-exclusive pact allows QuantuMDx to use the technology worldwide for DNA sequencing and biomarker detection applications. In exchange, QuantuMDx paid Palo Alto, Calif.-based Nanosys an upfront license fee and will make downstream royalty payments.

Further terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.